- Home
- PLD vs PFE Comparison
PLD vs PFE Comparison
Compare PLD & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLD | PFE |
|---|---|---|
| Founded | 1983 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 141.6B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLD | PFE |
|---|---|---|
| Price | $129.83 | $25.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 11 |
| Target Price | ★ $132.13 | $27.18 |
| AVG Volume (30 Days) | 3.1M | ★ 43.8M |
| Earning Date | 01-21-2026 | 02-03-2026 |
| Dividend Yield | 3.09% | ★ 6.74% |
| EPS Growth | 3.74 | ★ 131.89 |
| EPS | ★ 3.43 | 1.73 |
| Revenue | $9,100,544,000.00 | ★ $62,785,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.55 | N/A |
| P/E Ratio | $38.08 | ★ $14.78 |
| Revenue Growth | ★ 10.45 | 3.89 |
| 52 Week Low | $85.35 | $20.92 |
| 52 Week High | $134.94 | $27.69 |
Technical Indicators
Market Signals| Indicator | PLD | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 58.49 |
| Support Level | $127.36 | $25.09 |
| Resistance Level | $134.94 | $25.89 |
| Average True Range (ATR) | 2.64 | 0.50 |
| MACD | 0.21 | 0.07 |
| Stochastic Oscillator | 56.71 | 91.34 |
Price Performance
Historical ComparisonAbout PLD Prologis Inc.
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.3 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party assets under management. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.